Presently, around 80 types of prefilled syringes are available in the market, and several companies claim to be engaged in the manufacturing of both glass and plastic variants of such versatile drug delivery solutions, claims Roots Analysis

Market-Research

Prefilled syringes present an attractive packaging option that doubles as an easy-to-use drug delivery device, and a product life cycle management tool. Consequently, they have become indispensable within the modern healthcare industry.

To order this 800+ ... Read more

Submitted by Roots_Analysis on 2020-10-01 08:56.

The prefilled syringes market is projected to grow at an annualized rate of ~5%, till 2030

Pharmaceuticals

Roots Analysis has done a detailed study on Prefilled Syringes, covering key aspects of the industry’s evolution and identifying ... Read more

Submitted by Roots_Analysis on 2020-10-01 08:55.

The prefilled syringes market is estimated to be worth over USD 2.5 billion in 2030, predicts Roots Analysis

Pharmaceuticals

Despite having been available for more than two decades, the demand for prefilled syringes continues to grow, given the numerous benefits they offer over conventional injectable drug delivery systems

Roots Analysis is ... Read more

Submitted by Roots_Analysis on 2020-10-01 08:54.

The “Peptides and Macrocycle Drug Discovery: Services and Platforms Market, 2020-2030” report features an extensive study on the current market landscape and future of companies offering services for peptides and macrocycle drug discovery operations.

Market-Research

To order this detailed 180+ page report, please visit this link

Key Inclusions

A detailed

Submitted by Roots_Analysis on 2020-10-01 08:54.

More than 35 industry players claim to offer services for the identification, characterization and development of peptides and macrocycle-based pharmacological lead candidates, claims Roots Analysis

Pharmaceuticals

Drug discovery is challenging and involves several complexities. In order to continue to add new molecules their pipelines, drug developers are opting to outsource such operations to contract research organizations (CROs). Outsourcing of peptides and macrocycle drug discovery has

Submitted by Roots_Analysis on 2020-10-01 08:48.

The next generation immune checkpoint inhibitors and stimulators market is projected to grow at an annualized rate of ~10.5%, till 2030

Pharmaceuticals

Roots Analysis has done a detailed study on Peptides and Macrocycle Drug Discovery: Services and Platforms Market, 2020-2030, covering key ... Read more

Submitted by Roots_Analysis on 2020-10-01 08:47.

The peptides and macrocycle drug discovery services market is estimated to be worth USD 1.5 billion in 2030, predicts Roots Analysis

Pharmaceuticals

Given the recent developments in healthcare, supporting safety and efficacy of peptide and affiliated macrocycle drugs, the industry is presently witnessing an increase in discovery and development initiatives related to such therapeutic modalities.

Submitted by Roots_Analysis on 2020-10-01 08:47.

The “Peptide Therapeutics: Contract API Manufacturing Market, 2020-2030” report features an extensive study of the current market landscape and future opportunities associated with the contract manufacturing of therapeutic peptides.

Market-Research

To order this 250+ page report, please visit this link

Key Inclusions

A detailed

Submitted by Roots_Analysis on 2020-09-30 11:11.

Currently, around 50 companies claim to manufacture peptide-based therapeutics; such players also claim to be capable of providing a variety of additional services to their clients

Pharmaceuticals

The inherent advantages of peptide therapeutics, such as small size, low immunogenicity and better cellular uptake, has led to a rise in interest in such interventions. This is anticipated to create significant opportunities for CMOs offering peptide manufacturing services. However, in order to ... Read more

Submitted by Roots_Analysis on 2020-09-30 11:05.

Peptide Therapeutics: Contract API manufacturing market is projected to grow at an annualized rate of ~11.2%, till 2030

Pharmaceuticals

Roots Analysis has done a detailed study on Peptide Therapeutics: Contract API Manufacturing Market, 2020-2030, covering various ... Read more

Submitted by Roots_Analysis on 2020-09-30 11:02.

Peptide Therapeutics: Contract API manufacturing market is estimated to be worth USD 3.2 billion in 2030, predicts Roots Analysis

Market-Research

Given the growing demand for peptide drugs and the complexities associated with their development and production, relying on the superior technical expertise and experience of CMOs / CDMOs is presently a widely accepted business model

Submitted by Roots_Analysis on 2020-09-30 11:01.

Patient Recruitment and Retention Services, 2019-2030’ report offers a comprehensive study of the current scenario and future potential of the players providing patient enrollment and retention services. The study features an in-depth analysis, highlighti

Market-Research

To order this detailed 300+ page report, please visit this link

Key Inclusions

Submitted by Roots_Analysis on 2020-09-30 10:58.

Presently, close to 140 companies claim to be actively engaged in offering patient recruitment / retention services to the pharmaceutical and medical devices industries, employing a variety of outreach methods and solutions, claims Roots Analysis

Pharmaceuticals

A steadily increasing demand for study participants and the complexities associated with patient enrollment has imposed a significant burden on drug developer companies, prompting them to enlist the services of specialty service providers. Presently, close to 140 companies are

Submitted by Roots_Analysis on 2020-09-30 10:57.

The patient recruitment and retention services market is projected to grow at an annualized rate of ~5%, till 2030

Pharmaceuticals

Roots Analysis has done a detailed study on Patient Recruitment and Retention Services Market, 2019-2030, covering ... Read more

Submitted by Roots_Analysis on 2020-09-30 10:55.

The patient recruitment and retention services market is estimated to be worth USD 5.3 billion in 2030, predicts Roots Analysis

Pharmaceuticals

A steadily increasing demand for participants in clinical research studies, coupled to the complexities associated with patient enrolment, have prompted drug / therapy developers to outsource this process to specialty service providers

Submitted by Roots_Analysis on 2020-09-30 10:53.

The ‘Patient Recruitment and Retention Services, 2019-2030

Market-Research

Key Inclusions

A detailed assessment of the current market landscape, including information on drug developer(s),
A detailed assessment of the current market landscape of companies offering patient recruitment and retention services, including

Submitted by Roots_Analysis on 2020-09-30 10:11.

Presently, close to 140 companies claim to be actively engaged in offering patient recruitment / retention services

Market-Research

Submitted by Roots_Analysis on 2020-09-30 10:02.

The patient recruitment and retention services market is projected to grow at an annualized rate of ~5%, till 2030

Market-Research

Roots Analysis has done a detailed study on Patient Recruitment and Retention Services Market, 2019-2030, covering ... Read more

Submitted by Roots_Analysis on 2020-09-30 10:00.

The patient recruitment and retention services market is estimated to be worth USD 5.3 billion in 2030

Market-Research

Submitted by Roots_Analysis on 2020-09-30 09:58.

The “Peptide Therapeutics: Contract API Manufacturing Market, 2020-2030

Market-Research

Key Inclusions

A detailed review of the overall landscape of companies offering contract services for manufacturing of peptides, along with information on year of establishment, company size, scale of operation (preclinical, clinical and commercial), geographical

Submitted by Roots_Analysis on 2020-09-30 09:56.

Pages